Fig. 9From: Intra-carotid arterial transfusion of circulatory-derived autologous endothelial progenitor cells in rodent after ischemic stroke—evaluating the impact of therapeutic time points on prognostic outcomesInflammatory cell expressions in brain infarct zone at day 60 after acute IS. a–g Illustrating the immunofluorescent (IF) microscopic finding (× 400) for identification of positively stained glial fibrillary acidic protein (GFAP) cells (green color). Red color in c to g indicates the dye-stained implanted ECPs. h Analytical result of number of GFAP+ cells, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 vs. IS. i–o Illustrating the IF microscopic finding (× 400) for identification of microglia+ cells (green color). Red color in c to g indicates the dye-stained implanted ECPs. p Analytical result of number of microglial cells, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 vs. IS. Scale bars in the lower right corner represent 20 μm. All statistical analyses were performed by one-way ANOVA, followed by Bonferroni multiple-comparison post hoc test (n = 6 for each group). LCCA = left common carotid artery. SC = sham-operated control; IS = ischemic stroke (IS); EPC3h = EPC administration from LCCA at 3 h after acute IS; EPC3d = EPC administration from LCCA at day 3 after acute IS; EPC7d = EPC administration from LCCA at day 7 after acute IS; EPC14d = EPC administration from LCCA at day 14 after acute IS; EPC28d = EPC administration from LCCA at day 28 after acute ISBack to article page